The Impact of ASCT on Patients With Newly Diagnosed Multiple Myeloma Who Receive RVD Induction

Journal of Hematological Malignancies
doi 10.5430/jhm.v3n1p41
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Sciedu Press

Related search

Induction Therapy and Stem Cell Mobilization in Patients With Newly Diagnosed Multiple Myeloma

Stem Cells International
Cell BiologyMolecular Biology
2012English

Improvement in Renal Function and Its Impact on Survival in Patients With Newly Diagnosed Multiple Myeloma

Blood Cancer Journal
OncologyHematology
2015English

Impact of Vitamin D Deficiency on the Clinical Presentation and Prognosis of Patients With Newly Diagnosed Multiple Myeloma

American Journal of Hematology
Hematology
2009English

Prognostic Nomogram for the Overall Survival of Patients With Newly Diagnosed Multiple Myeloma

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2019English

Changes in Uninvolved Immunoglobulins During Induction Therapy for Newly Diagnosed Multiple Myeloma

Blood Cancer Journal
OncologyHematology
2017English

Daratumumab in Untreated Newly Diagnosed Multiple Myeloma

Therapeutic Advances in Hematology
Hematology
2019English

Chromosome 1 Abnormalities in Elderly Patients With Newly Diagnosed Multiple Myeloma Treated With Novel Therapies

Haematologica
Hematology
2014English

Peripheral Neuropathy Induced by Subcutaneous Bortezomib-Based Induction Therapy for Newly Diagnosed Multiple Myeloma

Haematologica
Hematology
2014English

Significance of Salvage Autologous Stem Cell Transplantation (ASCT) for Patients With Multiple Myeloma Relapsing After Up-Front ASCT

Journal of Hematopoietic Cell Transplantation
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy